To hear about similar clinical trials, please enter your email below
Trial Title:
Impact of a Collaborative Program of Physical Activity of Newly-diagnosed Cancer Patients
NCT ID:
NCT05723471
Condition:
Cancer
Conditions: Keywords:
Adaptative physical activity
Cancer
Quality of Life
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Adaptative Physical Activity
Description:
12 weeks of a collaborative program of customized, adaptative and supervised physical
activity by sports instructor
Arm group label:
Adaptative Physical Activity
Summary:
During the last twenty years, the cancer overall incidence has been increasing in europe
and developed countries, while diagnostic and therapeutic progress have contributes to a
reduction in mortality. Currently, almost 4 million people are treated or followed for
cancer in France. The physical, psychological and social after-effects are significant.
Adaptated physical activity plays an important role in the rehabilitation process.
Overall, meta-analyses carried-out with most frequent cancers demonstrate that physical
activity practiced would allow an improvement in quality of life, tolerance to anticancer
treatments and survival.
Detailed description:
This is a multicenter, two-arm parallel-group randomizes (in a 1:1 ratio), open-label,
controlled intervention clinical trial of the comparison of long term adherence to
physical activity between an adaptative, customized and collaborative exercise program
and standard exercise prescription in patients with newly diagnosed cancer.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- newly-diagnosed cancer patient
- able to start a program of physical activity within the first year follow diagnosis
- performance status between 0 to 2
Exclusion Criteria:
- uncontrolled cardiovascular disease
- peripheral neuropathy grade 3-4 with risk of falling
- bone metastasis with risk of bone fracture
- platelets <100X109/L
- hemoglobin <8g/dL
- patient under legal protection
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Stéphanie MOTTON
Address:
City:
Toulouse
Zip:
31059
Country:
France
Contact:
Last name:
Stéphanie MOTTON, MD
Phone:
0531155385
Phone ext:
33
Email:
motton.stephanie@iuct-oncopole.fr
Start date:
December 1, 2023
Completion date:
December 31, 2027
Lead sponsor:
Agency:
University Hospital, Toulouse
Agency class:
Other
Source:
University Hospital, Toulouse
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05723471
